References
- Capmas P, Lobersztajn A, Duminil L, Barral T, Pourcelot AG, Fernandez H. 2019. Operative hysteroscopy for retained products of conception: efficacy and subsequent fertility. Journal of Gynecology Obstetrics and Human Reproduction 48:151–154.
- Casikar I, Lu C, Oates J, Bignardi T, Alhamdan D, Condous G. 2012. The use of power Doppler color scoring to predict successful expectant management in women with an incomplete miscarriage. Human Reproduction 27:669–675.
- Combs CA, Laros RK Jr. 1991. Prolonged third stage of labor: morbidity and risk factors. Obstetrics and Gynecology 77:863–867.
- Hooker AB, Aydin H, Brölmann HA, Huirne JA. 2016. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertility and Sterility 105:156–164.
- Hoveyda F, MacKenzie IZ. 2001. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG 108:927–930.
- Kamaya A, Krishnarao PM, Nayak N, Jeffrey RB, Maturen KE. 2016. Clinical and imaging predictors of management in retained products of conception. Abdominal Radiology 41:2429–2434.
- Kanda Y. 2013. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplantation 48:452–458.
- Kitahara T, Sato Y, Kakui K, Tatsumi K, Fujiwara H, Konishi I. 2011. Management of retained products of conception with marked vascularity. The Journal of Obstetrics and Gynaecology Research 37:458–464.
- Mentula MJ, Niinimäki M, Suhonen S, Hemminki E, Gissler M, Heikinheimo O. 2011. Immediate adverse events after second trimester medical termination of pregnancy: results of a nationwide registry study. Human Reproduction 26:927–932.
- Mulic-Lutvica A, Eurenius K, Axelsson O. 2009. Uterine artery Doppler ultrasound in postpartum women with retained placental tissue. Acta Obstetricia et Gynecologica Scandinavica 88:724–728.
- Royal College of Obstetricians and Gynecologists (RCOG) Press. 2004. The care of women requesting induced abortion. RCOG Guideline, London.
- Romero R, Hsu YC, Athanassiadis AP, Hagay Z, Avila C, Nores J, et al. 1990. Preterm delivery: a risk factor for retained placenta. American Journal of Obstetrics and Gynecology 163:823–825.
- Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB Jr., Kamaya A. 2013. Physiologic, histologic, and imaging features of retained products of conception. Radiographics 33:781–796.
- Smorgick N, Mittler A, Ben-Ami I, Maymon R, Vaknin Z, Pansky M. 2018. Retained products of conception: what is the risk for recurrence on subsequent pregnancies? European Journal of Obstetrics, Gynecology, and Reproductive Biology 224:1–5.
- van den Bosch T, Daemen A, Van Schoubroeck D, Pochet N, De Moor B, Timmerman D. 2008. Occurrence and outcome of residual trophoblastic tissue: a prospective study. Journal of Ultrasound in Medicine 27:357–361.
- van der Knoop BJ, Vandenberghe G, Bolte AC, Go AT. 2012. Placental retention in late first and second trimester pregnancy termination using misoprostol: a retrospective analysis. The Journal of Maternal-Fetal & Neonatal Medicine 25:1287–1291.